Results 151 to 160 of about 1,311,031 (176)
Some of the next articles are maybe not open access.
The Prevalence of Vitreomacular Interface Pathology in a Spanish Tertiary Hospital
Ophthalmologica, 2016<b><i>Purpose:</i></b> To determine the prevalence of vitreomacular interface (VMI) pathology, using spectral-domain optical coherence tomography (SD-OCT). <b><i>Methods:</i></b> VMI status was classified into macular posterior vitreous detachment (PVD), focal vitreomacular adhesion (VMA; ≤1,500 μm ...
Josep M Caminal +2 more
exaly +3 more sources
The Efficacy and Safety Profile of Ocriplasmin in Vitreomacular Interface Disorders
Seminars in Ophthalmology, 2016Vitreomacular adhesion (VMA) describes the adhesion of the posterior hyaloid face to the inner retina in any part of the macula. This can arise after incomplete separation of the posterior vitreous cortex from the macula during vitreous liquefaction.
Mehrine, Shaikh +3 more
openaire +2 more sources
[Pathology of the vitreomacular interface].
Oftalmologia (Bucharest, Romania : 1990), 2014Vitreous role in the pathophysiology of retinal diseases has increased importantly over the recent years. This was possible using Optical Coherence Tomography which reviewed the way the vitreoretinal interface should be looked at and defined and classified new pathologies such as Vitreoretinal Traction Syndrome.
Monica, Pop, Alina, Gheorghe
openaire +1 more source
Retina, 2013
To review the role of optical coherence tomography (OCT) in diagnosis and management of vitreomacular disease and the impact of OCT on potential uses of ocriplasmin, a new pharmacologic vitreolysis agent recently approved by the U.S. Food and Drug Administration for the treatment of symptomatic vitreomacular adhesion.Analysis of current literature ...
Peter, Stalmans +7 more
openaire +2 more sources
To review the role of optical coherence tomography (OCT) in diagnosis and management of vitreomacular disease and the impact of OCT on potential uses of ocriplasmin, a new pharmacologic vitreolysis agent recently approved by the U.S. Food and Drug Administration for the treatment of symptomatic vitreomacular adhesion.Analysis of current literature ...
Peter, Stalmans +7 more
openaire +2 more sources
Ocriplasmin for treatment of the vitreomacular interface
2013Purpose: Vitreomacular adhesion (VMA) is implicated in the pathobiology of idiopathic vitreomacular traction (VMT) and macular hole (MH), and is associated with more severe disease in other conditions such as diabetic retinopathy, DME, and AMD. Methods: Two multi-center Phase III trials were performed[for full text, please go to the a.m. URL]
openaire +2 more sources
Refractive outcome comparison between vitreomacular interface disorders after phacovitrectomy
Journal of Cataract and Refractive Surgery, 2017To compare the refractive accuracy of intraocular lens (IOL) power calculations between patients with vitreomacular interface disorders who had phacovitrectomy for vitreomacular traction (VMT), epiretinal membranes (ERM), and macular holes.Baskent University Department of Ophthalmology, Ankara, Turkey.Retrospective case series.Refraction results 8 ...
Zeynep Eylül, Ercan +4 more
openaire +2 more sources
Frequency of Vitreomacular Interface Disease in Patients Presenting to a Tertiary Care Institution
Ophthalmic Surgery, Lasers and Imaging Retina, 2014BACKGROUND AND OBJECTIVE: To evaluate the frequency of vitreomacular interface disease using a recently published optical coherence tomography (OCT) classification and assess which of these patients would qualify for ocriplasmin.
Lucy T, Xu +6 more
openaire +2 more sources
Disorders of the vitreomacular interface
2016The vitreous is one of the largest structures within the eye, comprised of 98% water, and forming the majority -80% -of the water in the globe. The vitreous is attached firmly at the vitreous base, the disc, the macula, and over the retinal blood vessels.
openaire +1 more source
VITREOMACULAR INTERFACE SURGERY - STEP BY STEP
The monograph examines the pathology of the vitreomacular interface from the point of view of approaches to its surgical treatment. The diversity of clinical forms of its pathological conditions, the lack of uniform treatment principles and clinical recommendations sometimes complicate the work of an ophthalmologist in this area.openaire +1 more source
On correct clinical and pathogenetic OCT-based classification of vitreomacular interface pathologies
Russian Annals of OphthalmologyCurrently, there is no universally accepted classification of vitreomacular interface (VMI) pathology, which complicates professional communication and the choice of treatment strategies. Purpose. This article presents our perspective on a feasible and prognostically significant clinical and pathogenetic OCT-based classification of surgical VMI ...
S.A. Kovalev +2 more
openaire +2 more sources

